When to Think About Other Borreliae:: Hard Tick Relapsing Fever (Borrelia miyamotoi), Borrelia mayonii, and Beyond

Kyle G Rodino; Bobbi S Pritt

doi:10.1016/j.idc.2022.04.002

When to Think About Other Borreliae:: Hard Tick Relapsing Fever (Borrelia miyamotoi), Borrelia mayonii, and Beyond

Infect Dis Clin North Am. 2022 Sep;36(3):689-701. doi: 10.1016/j.idc.2022.04.002.

Authors

Kyle G Rodino¹, Bobbi S Pritt²

Affiliations

¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
² Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA. Electronic address: Pritt.bobbi@mayo.edu.

PMID: 36116843
DOI: 10.1016/j.idc.2022.04.002

Abstract

In North America, several hard tick-transmitted Borrelia species other than Borrelia burgdorferi cause human disease, including Borrelia miyamotoi, Borrelia mayonii, and possibly Borrelia bissettii. Due to overlapping clinical syndromes, nonspecific tickborne disease (TBD) testing strategies, and shared treatment approaches, infections with these lesser known Borrelia are likely under-reported. In this article, we describe the epidemiology, clinical manifestations, diagnosis, and treatment of these less common Borrelia pathogens.

Keywords: Lyme disease; Relapsing fever; Tickborne.

Publication types

Review

MeSH terms

Animals
Borrelia*
Humans
Ixodidae*
Relapsing Fever* / diagnosis
Relapsing Fever* / drug therapy
Relapsing Fever* / epidemiology
Spirochaetales

Supplementary concepts

Borrelia mayonii
Borrelia miyamotoi